Literature DB >> 30292329

Devil in the Detail: Intratumour Heterogeneity and Personalised Medicine for Bladder Cancer.

Jon L Griffin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30292329     DOI： 10.1016/j.eururo.2018.09.036

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

Review 1.  Contemporary Molecular Classification of Urinary Bladder Cancer.

Authors:  Dimitrios Goutas; Andrianos Tzortzis; Harikleia Gakiopoulou; Dimitrios Vlachodimitropoulos; Ioanna Giannopoulou; Andreas C Lazaris
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis.

Authors:  Yuying Han; Xu Liu; Haihong Ye; Ye Tian; Zhengguo Ji
Journal:  World J Surg Oncol       Date:  2020-11-26       Impact factor: 2.754
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.